author-photo

M. Borms

AZ Groeninge

18

Papers

103

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

Abstract PS9-06: Adherence to and patient satisfaction with the combination therapy of exemestane and everolimus in postmenopausal women with HR+ HER2- advanced breast cancer: Results from the IPSOC-mamma study

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
PSMA expression on neovasculature of solid tumors.

2020 Histology and Histopathology
Show All
- Source
- Cite
- Save
Citations (7)
Abstract P4-22-22: Cobimetinib (C) combined with paclitaxel (P) as a first-line treatment in patients (pts) with advanced triple-negative breast cancer (COLET study): Updated clinical and biomarker results

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
First-line cobimetinib (C) + paclitaxel (P) in patients (pts) with advanced triple-negative breast cancer (TNBC): Updated results and tumoral immune cell infiltration data from the phase 2 COLET study

2016 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Everolimus (EVE) plus exemestane (EXE) in elderly patients (pts) with hormone receptor-positive (HR+), human epidermal growth receptor-2 negative (HER2-) advanced breast cancer (ABC) progressing on prior nonsteroidal aromatase inhibitors (NSAIs) : Insights on safety form BALLET (CRAD001YIC04)

2016
Show All
- Source
- Cite
- Save
Citations (0)
1850 Safety of everolimus plus exemestane in elderly patients with Hormone-Receptor-Positive (HR+), HER2- locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors (NSAIs): BALLET (CRAD001YIC04)

2015 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Stable metabolic disease on FDG-PET provides information on response to endocrine therapy for breast cancer

2014 Quarterly Journal of Nuclear Medicine and Molecular Imaging
Show All
- Source
- Cite
- Save
Citations (2)
The 2006 Adjuvant Trastuzumab Convention in Belgium: 5 years later

2012 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Fulvestrant (Faslodex) in advanced breast cancer: clinical experience from a Belgian cooperative study.

2008 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (17)
Phosphorylated HER-2 tyrosine kinase and Her-2/neu gene amplification as predictive factors of response to trastuzumab in patients with HER-2 overexpressing metastatic breast cancer (MBC).

2007 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (41)